Emerging Healthcare Solutions, Inc. (PinkSheets: EHSI) announced today that it has entered into an option agreement with TraumaTec, Inc., the owner of the breakthrough Neuro-Wrap medical device.

During the 60-day option period, EHSI will conduct a due-diligence review of TramaTec and its prospects in order to negotiate a potential investment and profit-sharing agreement. TraumaTec’s Neuro-Wrap device is designed to rapidly and safely deliver selective brain cooling in order to minimize neuronal injury and improve outcome in patients suffering cardiac arrest, stroke, or traumatic brain injury. Selective brain cooling helps avoid the complications seen with full-body cooling.

“Millions of patients suffer brain injuries and other traumatic afflictions each year, and selective brain cooling has proven to improve their recovery,” said EHSI President and CEO Cindy Morrissey. “TraumaTec has come up with an innovative, effective medical device in the Neuro-Wrap, and we’re pleased to move forward in our relationship with them.”

Emerging Healthcare Solutions focuses on the development of profitable emerging medical technology, a sector that also includes Amgen (NASDAQ: AMGN), Dendreon Corporation (NASDAQ: DNDN), Smith & Nephew PLC (NYSE: SNN) and Pharmaceutical Product Development (NASDAQ: PPDI).

About Emerging Healthcare Solutions, Inc.

Emerging Healthcare Solutions, Inc. invests in and participates in the profits of emerging breakthrough medical technologies. The Company believes the secret of leveraging future value for its shareholders is the proper timing of its investment in promising new medical technologies. EHSI aims to capture future profits of promising new medical technologies by investing in these technologies at the inflection point of product development. We believe this model will deliver long-term positive results for our investors.

For more information, please visit http://www.EmergingHealthcareSolutionsInc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.